Abstract
Treating urinary incontinence and sexual dysfunction in Parkinson’s disease (PD) involves a multicomponent approach. This incorporates patient goals for care and prioritizes lifestyle and behavioral therapy prior to the initiation of drug therapy in order to avoid adverse drug events. In addition to a targeted exam and careful medication review, assessment of mobility and cognitive function are important to develop patient-centered approaches to care. Pelvic floor muscle exercise-based behavioral therapy is a reasonable first approach to treat urinary symptoms. Drug therapy for urinary incontinence may involve bladder relaxants and/or treatments for concomitant bladder outlet obstruction in men. After evaluation of comorbid conditions and medications affecting sexual function, education regarding treatment options and specialist referral may be considered. Phosphodiesterase inhibitors should be used with caution in men with orthostatic hypotension, and limited evidence suggests efficacy for erectile dysfunction in PD.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSuggested Reading
Bronner G. Practical strategies for the management of sexual problems in Parkinson’s disease. Parkin Relat Disord. 2009;15S3:S96–S100.
Factor SA, Bennett AJ, Hohler AD, Wang D, Miyasaki JM. Quality improvement in neurology: Parkinson disease update quality measurement set: executive summary. Neurology. 2016;86(24):2278–83.
Gallagher DA, Lees AJ, Schrag A. What are the most important nonmotor symptoms in patients with Parkinson’s disease and are we missing them? Mov Disord. 2010;25(15):2493–500.
Sakakibara R, Panicker J, Finazzi-Agro E, Iacovelli V, Bruschini H. A guideline for the management of bladder dysfunction in Parkinson’s disease and other gait disorders. Neurourol Urodyn. 2016;35:551–63.
Seppi K, Weintraub D, Coelho M, et al. The movement disorder society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson’s disease. Mov Disord. 2011;26:S42–80.
Vaughan CP, Juncos JL, Burgio KL, et al. Behavioral therapy to treat urinary incontinence in Parkinson disease. Neurology. 2011;76:1631–4.
Zesiewicz TA, Sullivan KL, Arnulf I, et al. Practice parameter: treatment of nonmotor symptoms of Parkinson disease: report of the quality standards Subcommittee of the American Academy of Neurology. Neurology. 2010;74:924–31.
Zesiewicz TA, Evatt M, Vaughan CP, et al. Randomized, controlled pilot trial of solifenacin succinate for overactive bladder in Parkinson’s disease. Parkin Relat Disord. 2015;21:514–20.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Vaughan, C.P. (2019). Treatment of Urinary and Sexual Dysfunction in Parkinson’s Disease. In: Reich, S., Factor, S. (eds) Therapy of Movement Disorders. Current Clinical Neurology. Humana, Cham. https://doi.org/10.1007/978-3-319-97897-0_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-97897-0_14
Published:
Publisher Name: Humana, Cham
Print ISBN: 978-3-319-97896-3
Online ISBN: 978-3-319-97897-0
eBook Packages: MedicineMedicine (R0)